What are the major opportunities in the Irritable Bowel Syndrome (IBS) Treatment market? What are the strategies for the Irritable Bowel Syndrome (IBS) Treatment market?

For detailed insights on the major opportunities and strategies in the Irritable Bowel Syndrome (IBS) Treatment market, Read More

How does the Irritable Bowel Syndrome (IBS) Treatment market relate to the overall economy and other similar markets?

For detailed insights on Irritable Bowel Syndrome (IBS) Treatment's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Irritable Bowel Syndrome (IBS) Treatment market growth? SWOT analysis of the Irritable Bowel Syndrome (IBS) Treatment market.

For detailed insights on the key dynamics influencing the Irritable Bowel Syndrome (IBS) Treatment market growth and SWOT analysis of the Irritable Bowel Syndrome (IBS) Treatment industry, Read More

Irritable Bowel Syndrome (IBS) Treatment Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Irritable Bowel Syndrome (IBS) Treatment Market Report 2026

Name: Irritable Bowel Syndrome (IBS) Treatment Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Type (Eluxadoline, Alosetron, Other Drugs), By Indication (IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-Users (Hospitals, Clinics, Homecare Settings) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Irritable Bowel Syndrome (IBS) Treatment Market Overview

• Irritable Bowel Syndrome (IBS) Treatment market size has reached to $7.41 billion in 2025

• Expected to grow to $10.65 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%

• Growth Driver: Rising Prevalence Of IBS Fueling The Growth Of The Market Due To Expanding Patient Population And Awareness

• Market Trend: Integration of Digital Therapeutics to Enhance Patient-Centric Gastrointestinal Care

• North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Irritable Bowel Syndrome (IBS) Treatment Market?

Irritable bowel syndrome (IBS) treatment refers to the various approaches and interventions aimed at treating gastrointestinal tract disorders, which are frequent disorders that affect the stomach and intestines. It is used to alleviate constipation, diarrhea, and abdominal symptoms, minimize the frequency and severity of flare-ups, and enhance overall well-being.

The main types of irritable bowel syndrome (IBS) treatment drugs are lubiprostone, linaclotide, eluxadoline, rifaximin, alosetron, and others. Lubiprostone is a medication used in the treatment of irritable bowel syndrome (IBS), and it is a selective chloride channel activator that helps to increase fluid secretion in the intestines. The various indications include IBS with constipation, IBS with diarrhea, and IBS with alternating constipation and diarrhea. These are sold through several types of distribution channels, such as hospital pharmacies, online pharmacies, and retail pharmacies, to various end-users, including hospitals, clinics, and home care settings.

Irritable Bowel Syndrome (IBS) Treatment Market Global Report 2026 Market Report bar graph

What Is The Irritable Bowel Syndrome (IBS) Treatment Market Size and Share 2026?

The irritable bowel syndrome (ibs) treatment market size has grown strongly in recent years. It will grow from $7.41 billion in 2025 to $7.97 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising prevalence of gastrointestinal disorders, increased diagnosis rates of ibs, growing awareness of digestive health, availability of prescription ibs drugs, expansion of hospital and retail pharmacy networks.

What Is The Irritable Bowel Syndrome (IBS) Treatment Market Growth Forecast?

The irritable bowel syndrome (ibs) treatment market size is expected to see strong growth in the next few years. It will grow to $10.65 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to advancement in precision medicine, increasing adoption of digital health platforms, growth in online pharmacy channels, rising focus on microbiome research, increasing healthcare expenditure on chronic conditions. Major trends in the forecast period include precision medicine and microbiome-based therapies, digital therapeutics and mobile health integration, AI-driven ibs diagnosis and treatment optimization, remote patient monitoring and smart gut health devices, sustainable and patient-centric drug development.

Book your 30 minutes free consultation with our research experts

Global Irritable Bowel Syndrome (IBS) Treatment Market Segmentation

1) By Drug Type: Eluxadoline, Alosetron, Other Drugs

2) By Indication: IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

4) By End-Users: Hospitals, Clinics, Homecare Settings

Subsegments:

1) By Eluxadoline: IBS with Diarrhea (IBS-D) Treatment, Moderate IBS-D Treatment

2) By Alosetron: Severe IBS-D Treatment for Women, Refractory IBS-D Treatment

3) By Other Drugs: Prucalopride, Tenapanor, Plecanatide

What Is The Driver Of The Irritable Bowel Syndrome (IBS) Treatment Market?

The rising prevalence of IBS is expected to propel the growth of the IBS treatment market going forward. Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder affecting the large intestine, causing symptoms such as constipation, diarrhea, abdominal pain, and bloating, and significantly impacting quality of life. The increase in IBS prevalence is due to lifestyle factors, including poor diet, stress, and environmental exposures, which contribute to more individuals developing the disorder. The IBS treatment market supports patient needs by providing both pharmacological therapies, such as antispasmodics and gut-targeted medications, and non-pharmacological interventions, including cognitive behavioral therapy, hypnotherapy, and dietary management. For instance, in December 2023, according to the IBD Registry, a UK-based non-profit organization, reaching over 5,300 individuals with Inflammatory Bowel Disease (IBD) by 2023, this represents an increase of more than 3,000 members compared to 2022. Therefore, the rising prevalence of IBS is driving the growth of the IBS treatment market.

Key Players In The Global Irritable Bowel Syndrome (IBS) Treatment Market

Major companies operating in the irritable bowel syndrome (ibs) treatment market are Ironwood Pharmaceuticals Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Pfizer Inc., Johnson & Johnson Services Inc., AstraZeneca plc, Novartis AG, Abbott Laboratories, Eli Lilly and Company, Astellas Pharma Inc., Bausch Health Companies Inc., Sebela Pharmaceuticals Inc., Prometheus Laboratories Inc., RedHill Biopharma Ltd., Ardelyx Inc., Renexxion Ireland Ltd., 4D Pharma plc, Biora Therapeutics Inc., Salix Pharmaceuticals Ltd., Allergan plc, Synergy Pharmaceuticals Inc.

Global Irritable Bowel Syndrome (IBS) Treatment Market Trends and Insights

Major companies operating in the irritable bowel syndrome (IBS) treatment market are focusing on incorporating digital therapeutics such as gut-directed hypnotherapy–based mobile applications to enhance patient engagement, treatment accessibility, and symptom management. Gut-directed hypnotherapy–based mobile applications are prescription digital platforms that deliver structured hypnotherapy sessions through a smartphone interface to modulate gut–brain interaction, enabling capabilities such as guided behavioural therapy, real-time symptom tracking, and automated patient-progress monitoring. For instance, in May 2023, Launchit DTx, a Canada-based digital health commercialization company, launched Regulora, a gut-directed hypnotherapy–based digital therapeutic designed to help adults manage abdominal pain associated with irritable bowel syndrome (IBS), featuring evidence-based hypnotherapy modules, clinician-enabled prescribing workflows, and a mobile app that tracks patient response over time. Regulora improves treatment access, self-management, and overall symptom relief for IBS patients by offering a non-pharmacologic, digitally delivered therapeutic option.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Irritable Bowel Syndrome (IBS) Treatment Market?

In October 2023, Roche, a Switzerland-based healthcare company acquired Telavant Holdings for an undisclosed amount. Through the acquisition, Roche will obtain the rights to develop, manufacture, and market a novel treatment for Irritable Bowel Syndrome (IBS) in the United States and Japan. Telavant Holdings is a US-based biotechnology company focusing on the development and commercialization of innovative therapies for inflammatory and fibrotic diseases.

Regional Outlook

North America was the largest region in the irritable bowel syndrome (IBS) treatment market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Irritable Bowel Syndrome (IBS) Treatment Market?

The irritable bowel syndrome (IBS) treatment market includes revenues earned by entities by providing services such as consultation, cognitive-behavioral therapy (CBT), hypnotherapy, psychological therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The irritable bowel syndrome (IBS) market also includes sales of antispasmodics, fiber supplements, laxatives, probiotics, and certain medications targeting gut function. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Irritable Bowel Syndrome (IBS) Treatment Market Report 2026?

The irritable bowel syndrome (ibs) treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the irritable bowel syndrome (ibs) treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Irritable Bowel Syndrome (IBS) Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$7.97 billion
Revenue Forecast In 2035	$10.65 billion
Growth Rate	CAGR of 7.6% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Type, Indication, Distribution Channel, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Ironwood Pharmaceuticals Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Pfizer Inc., Johnson & Johnson Services Inc., AstraZeneca plc, Novartis AG, Abbott Laboratories, Eli Lilly and Company, Astellas Pharma Inc., Bausch Health Companies Inc., Sebela Pharmaceuticals Inc., Prometheus Laboratories Inc., RedHill Biopharma Ltd., Ardelyx Inc., Renexxion Ireland Ltd., 4D Pharma plc, Biora Therapeutics Inc., Salix Pharmaceuticals Ltd., Allergan plc, Synergy Pharmaceuticals Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Irritable Bowel Syndrome (IBS) Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Irritable Bowel Syndrome (IBS) Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Irritable Bowel Syndrome (IBS) Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Irritable Bowel Syndrome (IBS) Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Precision Medicine And Microbiome-Based Therapies

4.2.2 Digital Therapeutics And Mobile Health Integration

4.2.3 Ai-Driven Ibs Diagnosis And Treatment Optimization

4.2.4 Remote Patient Monitoring And Smart Gut Health Devices

4.2.5 Sustainable And Patient-Centric Drug Development

5. Irritable Bowel Syndrome (IBS) Treatment Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Gastroenterology Clinics

5.3 Specialty Clinics

5.4 Homecare Settings

5.5 Ambulatory Care Centers

6. Irritable Bowel Syndrome (IBS) Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Irritable Bowel Syndrome (IBS) Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Irritable Bowel Syndrome (IBS) Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Irritable Bowel Syndrome (IBS) Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Irritable Bowel Syndrome (IBS) Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Irritable Bowel Syndrome (IBS) Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Irritable Bowel Syndrome (IBS) Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Irritable Bowel Syndrome (IBS) Treatment Market Segmentation

9.1. Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Eluxadoline, Alosetron, Other Drugs

9.2. Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea

9.3. Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

9.4. Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Homecare Settings

9.5. Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Eluxadoline, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

IBS with Diarrhea (IBS-D) Treatment, Moderate IBS-D Treatment

9.6. Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Alosetron, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Severe IBS-D Treatment for Women, Refractory IBS-D Treatment

9.7. Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prucalopride, Tenapanor, Plecanatide

10. Irritable Bowel Syndrome (IBS) Treatment Market Regional And Country Analysis

10.1. Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market

11.1. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Irritable Bowel Syndrome (IBS) Treatment Market

12.1. China Irritable Bowel Syndrome (IBS) Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Irritable Bowel Syndrome (IBS) Treatment Market

13.1. India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Irritable Bowel Syndrome (IBS) Treatment Market

14.1. Japan Irritable Bowel Syndrome (IBS) Treatment Market Overview

14.2. Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Irritable Bowel Syndrome (IBS) Treatment Market

15.1. Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Irritable Bowel Syndrome (IBS) Treatment Market

16.1. Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Irritable Bowel Syndrome (IBS) Treatment Market

17.1. South Korea Irritable Bowel Syndrome (IBS) Treatment Market Overview

17.2. South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Irritable Bowel Syndrome (IBS) Treatment Market

18.1. Taiwan Irritable Bowel Syndrome (IBS) Treatment Market Overview

18.2. Taiwan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Irritable Bowel Syndrome (IBS) Treatment Market

19.1. South East Asia Irritable Bowel Syndrome (IBS) Treatment Market Overview

19.2. South East Asia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market

20.1. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market Overview

20.2. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Irritable Bowel Syndrome (IBS) Treatment Market

21.1. UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Irritable Bowel Syndrome (IBS) Treatment Market

22.1. Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Irritable Bowel Syndrome (IBS) Treatment Market

23.1. France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Irritable Bowel Syndrome (IBS) Treatment Market

24.1. Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Irritable Bowel Syndrome (IBS) Treatment Market

25.1. Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market

26.1. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market Overview

26.2. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Irritable Bowel Syndrome (IBS) Treatment Market

27.1. Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Irritable Bowel Syndrome (IBS) Treatment Market

28.1. North America Irritable Bowel Syndrome (IBS) Treatment Market Overview

28.2. North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Irritable Bowel Syndrome (IBS) Treatment Market

29.1. USA Irritable Bowel Syndrome (IBS) Treatment Market Overview

29.2. USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Irritable Bowel Syndrome (IBS) Treatment Market

30.1. Canada Irritable Bowel Syndrome (IBS) Treatment Market Overview

30.2. Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Irritable Bowel Syndrome (IBS) Treatment Market

31.1. South America Irritable Bowel Syndrome (IBS) Treatment Market Overview

31.2. South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Irritable Bowel Syndrome (IBS) Treatment Market

32.1. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Irritable Bowel Syndrome (IBS) Treatment Market

33.1. Middle East Irritable Bowel Syndrome (IBS) Treatment Market Overview

33.2. Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Irritable Bowel Syndrome (IBS) Treatment Market

34.1. Africa Irritable Bowel Syndrome (IBS) Treatment Market Overview

34.2. Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Irritable Bowel Syndrome (IBS) Treatment Market Regulatory and Investment Landscape

36. Irritable Bowel Syndrome (IBS) Treatment Market Competitive Landscape And Company Profiles

36.1. Irritable Bowel Syndrome (IBS) Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Irritable Bowel Syndrome (IBS) Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Irritable Bowel Syndrome (IBS) Treatment Market Company Profiles

36.3.1. Ironwood Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Irritable Bowel Syndrome (IBS) Treatment Market Other Major And Innovative Companies

AstraZeneca plc, Novartis AG, Abbott Laboratories, Eli Lilly and Company, Astellas Pharma Inc., Bausch Health Companies Inc., Sebela Pharmaceuticals Inc., Prometheus Laboratories Inc., RedHill Biopharma Ltd., Ardelyx Inc., Renexxion Ireland Ltd., 4D Pharma plc, Biora Therapeutics Inc., Salix Pharmaceuticals Ltd., Allergan plc

38. Global Irritable Bowel Syndrome (IBS) Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Irritable Bowel Syndrome (IBS) Treatment Market

40. Irritable Bowel Syndrome (IBS) Treatment Market High Potential Countries, Segments and Strategies

40.1 Irritable Bowel Syndrome (IBS) Treatment Market In 2030 - Countries Offering Most New Opportunities

40.2 Irritable Bowel Syndrome (IBS) Treatment Market In 2030 - Segments Offering Most New Opportunities

40.3 Irritable Bowel Syndrome (IBS) Treatment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Irritable Bowel Syndrome (IBS) Treatment Market, Overview Of Key Products - Product Examples

Table 2: Global Irritable Bowel Syndrome (IBS) Treatment Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Irritable Bowel Syndrome (IBS) Treatment Market, Supply Chain Analysis

Table 4: Global Irritable Bowel Syndrome (IBS) Treatment Market, Major Raw Material Providers

Table 5: Global Irritable Bowel Syndrome (IBS) Treatment Market, Major Resource Providers

Table 6: Global Irritable Bowel Syndrome (IBS) Treatment Market, Major Manufacturers (Suppliers)

Table 7: Global Irritable Bowel Syndrome (IBS) Treatment Market, Major Distributors And Channel Partners

Table 8: Global Irritable Bowel Syndrome (IBS) Treatment Market, Key Technologies & Future Trends

Table 9: Global Irritable Bowel Syndrome (IBS) Treatment Market, Major Trends

Table 10: Global Irritable Bowel Syndrome (IBS) Treatment Market, Major End Users

Table 11: Global Irritable Bowel Syndrome (IBS) Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Irritable Bowel Syndrome (IBS) Treatment Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Irritable Bowel Syndrome (IBS) Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Irritable Bowel Syndrome (IBS) Treatment Market - TAM, US$ Billion, 2025

Table 15: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Eluxadoline, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Alosetron, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Irritable Bowel Syndrome (IBS) Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Irritable Bowel Syndrome (IBS) Treatment Market - Company Scoring Matrix

Table 98: Ironwood Pharmaceuticals Inc. Financial Performance

Table 99: AbbVie Inc. Financial Performance

Table 100: Takeda Pharmaceutical Company Limited Financial Performance

Table 101: Pfizer Inc. Financial Performance

Table 102: Johnson & Johnson Services Inc. Financial Performance

Table 103: Global Irritable Bowel Syndrome (IBS) Treatment Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Irritable Bowel Syndrome (IBS) Treatment Market, Competitive Dashboard

Table 105: Global Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Table 107: Global, Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Table 108: Global, Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Irritable Bowel Syndrome (IBS) Treatment Market, Overview Of Key Products - Product Examples

Figure 2: Global Irritable Bowel Syndrome (IBS) Treatment Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Irritable Bowel Syndrome (IBS) Treatment Market, Supply Chain Analysis

Figure 4: Global Irritable Bowel Syndrome (IBS) Treatment Market, Major Raw Material Providers

Figure 5: Global Irritable Bowel Syndrome (IBS) Treatment Market, Major Resource Providers

Figure 6: Global Irritable Bowel Syndrome (IBS) Treatment Market, Major Manufacturers (Suppliers)

Figure 7: Global Irritable Bowel Syndrome (IBS) Treatment Market, Major Distributors And Channel Partners

Figure 8: Global Irritable Bowel Syndrome (IBS) Treatment Market, Key Technologies & Future Trends

Figure 9: Global Irritable Bowel Syndrome (IBS) Treatment Market, Major Trends

Figure 10: Global Irritable Bowel Syndrome (IBS) Treatment Market, Major End Users

Figure 11: Global Irritable Bowel Syndrome (IBS) Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Irritable Bowel Syndrome (IBS) Treatment Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Irritable Bowel Syndrome (IBS) Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Irritable Bowel Syndrome (IBS) Treatment Market - TAM, US$ Billion, 2025

Figure 15: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Eluxadoline, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Alosetron, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Irritable Bowel Syndrome (IBS) Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Irritable Bowel Syndrome (IBS) Treatment Market - Company Scoring Matrix

Figure 98: Ironwood Pharmaceuticals Inc. Financial Performance

Figure 99: AbbVie Inc. Financial Performance

Figure 100: Takeda Pharmaceutical Company Limited Financial Performance

Figure 101: Pfizer Inc. Financial Performance

Figure 102: Johnson & Johnson Services Inc. Financial Performance

Figure 103: Global Irritable Bowel Syndrome (IBS) Treatment Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Irritable Bowel Syndrome (IBS) Treatment Market, Competitive Dashboard

Figure 105: Global Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Figure 107: Global, Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Figure 108: Global, Irritable Bowel Syndrome (IBS) Treatment Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Inflammatory Bowel Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Cro...

Bowel Management Systems Market Report 2026 - Global Outlook – By Product (Colostomy Bags, Irrigation Systems, Nerve Modulation Devices, Other Products), By Patient Type (Adults, Pediatric), By End-User (Hospitals, Ambul...

Constipation Treatment Market Report 2026 - Global Outlook – By Therapeutic Types (Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, Guanylate Cyclase-C (GC-C) Agonists, Other Th...

Crohn's Disease Treatment Market Report 2026 - Global Outlook – By Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types), By Distribution Channel (Hospital Pharmacies, Retail Pha...

Constipation Laxative Market Report 2026 - Global Outlook – By Drug Type (Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxative, Other Drugs), By Route Of Administration (Oral, Rectal), By Distribution Channel (H...

Opioid-Induced Constipation Treatment Market Report 2026 - Global Outlook – By Drug Class (Laxatives, Peripherally Acting µ-opioid Receptor Antagonists, Serotonin Receptor Agonists), By Type (Oral, Parenteral), By Distri...

Ulcerative Colitis Market Report 2026 - Global Outlook – By Drug Type (Anti-Inflammatory Drugs, Anti-TNF Biologics, Immunosuppressant, Calcineurin Inhibitors, Other Drug Types), By Disease Type (Ulcerative Proctitis, Pro...

Frequently Asked Questions

How big is the Irritable Bowel Syndrome (IBS) Treatment Market?

The Irritable Bowel Syndrome (IBS) Treatment market was valued at $7.41 billion in 2025, increased to $7.97 billion in 2026, and is projected to reach $10.65 billion by 2030. request a sample here

What is the Irritable Bowel Syndrome (IBS) Treatment market growth?

The global Irritable Bowel Syndrome (IBS) Treatment market is expected to grow at a CAGR of 7.5% from 2026 to 2035 to reach $10.65 billion by 2035. request a sample here

Who are the key players in Irritable Bowel Syndrome (IBS) Treatment market?

Some Key Players in the Irritable Bowel Syndrome (IBS) Treatment market Include, Ironwood Pharmaceuticals Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Pfizer Inc., Johnson & Johnson Services Inc., AstraZeneca plc, Novartis AG, Abbott Laboratories, Eli Lilly and Company, Astellas Pharma Inc., Bausch Health Companies Inc., Sebela Pharmaceuticals Inc., Prometheus Laboratories Inc., RedHill Biopharma Ltd., Ardelyx Inc., Renexxion Ireland Ltd., 4D Pharma plc, Biora Therapeutics Inc., Salix Pharmaceuticals Ltd., Allergan plc, Synergy Pharmaceuticals Inc. . request a sample here

What is the anticipated growth trend for the Irritable Bowel Syndrome (IBS) Treatment market?

Major trend in this market includes: Integration of Digital Therapeutics to Enhance Patient-Centric Gastrointestinal Care. For further insights on this market. request a sample here

Which region has the most growth potential in the Irritable Bowel Syndrome (IBS) Treatment market?

North America was the largest region in the irritable bowel syndrome (IBS) treatment market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the irritable bowel syndrome (ibs) treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Irritable Bowel Syndrome (IBS) Treatment Market Report 2026 market?

Major companies operating in the Irritable Bowel Syndrome (IBS) Treatment Market Report 2026 market are Major companies operating in the irritable bowel syndrome (ibs) treatment market are Ironwood Pharmaceuticals Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Pfizer Inc., Johnson & Johnson Services Inc., AstraZeneca plc, Novartis AG, Abbott Laboratories, Eli Lilly and Company, Astellas Pharma Inc., Bausch Health Companies Inc., Sebela Pharmaceuticals Inc., Prometheus Laboratories Inc., RedHill Biopharma Ltd., Ardelyx Inc., Renexxion Ireland Ltd., 4D Pharma plc, Biora Therapeutics Inc., Salix Pharmaceuticals Ltd., Allergan plc, Synergy Pharmaceuticals Inc. request a sample here.

Which region has the most growth potential in the Irritable Bowel Syndrome (IBS) Treatment Market Report 2026 market?